<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001678984</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001479290</issuerCik>
            <issuerName>REVANCE THERAPEUTICS, INC.</issuerName>
            <secFileNumber>001-36297</secFileNumber>
            <issuerAddress>
                <ns2:street1>1222 Demonbreun Street, Suite 2000</ns2:street1>
                <ns2:city>Nashville</ns2:city>
                <ns2:stateOrCountry>TN</ns2:stateOrCountry>
                <ns2:zipCode>37203</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>(615) 724-7755</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>TOBIN SCHILKE</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>E*TRADE FINANCIAL CORPORATION</name>
                <address>
                    <ns2:street1>3 EDISON DRIVE</ns2:street1>
                    <ns2:city>ALPHARETTA</ns2:city>
                    <ns2:stateOrCountry>GA</ns2:stateOrCountry>
                    <ns2:zipCode>30005</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>500</noOfUnitsSold>
            <aggregateMarketValue>15500.00</aggregateMarketValue>
            <noOfUnitsOutstanding>84040352</noOfUnitsOutstanding>
            <approxSaleDate>06/02/2023</approxSaleDate>
            <securitiesExchangeName>NASD</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>COMMON</securitiesClassTitle>
            <acquiredDate>02/15/2021</acquiredDate>
            <natureOfAcquisitionTransaction>Restricted Stock</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>500</amountOfSecuritiesAcquired>
            <paymentDate>02/15/2021</paymentDate>
            <natureOfPayment>Not Applicable</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>TOBIN SCHILKE</name>
                <address>
                    <ns2:street1>1222 Demonbreun Street, Suite 2000</ns2:street1>
                    <ns2:city>Nashville</ns2:city>
                    <ns2:stateOrCountry>TN</ns2:stateOrCountry>
                    <ns2:zipCode>37203</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>06/01/2023</saleDate>
            <amountOfSecuritiesSold>2701</amountOfSecuritiesSold>
            <grossProceeds>82569.57</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>TOBIN SCHILKE</name>
                <address>
                    <ns2:street1>1222 Demonbreun Street, Suite 2000</ns2:street1>
                    <ns2:city>Nashville</ns2:city>
                    <ns2:stateOrCountry>TN</ns2:stateOrCountry>
                    <ns2:zipCode>37203</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>common</securitiesClassTitle>
            <saleDate>05/15/2023</saleDate>
            <amountOfSecuritiesSold>21401</amountOfSecuritiesSold>
            <grossProceeds>738674.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>TOBIN SCHILKE</name>
                <address>
                    <ns2:street1>1222 Demonbreun Street, Suite 2000</ns2:street1>
                    <ns2:city>Nashville</ns2:city>
                    <ns2:stateOrCountry>TN</ns2:stateOrCountry>
                    <ns2:zipCode>37203</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>05/01/2023</saleDate>
            <amountOfSecuritiesSold>3201</amountOfSecuritiesSold>
            <grossProceeds>101471.70</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>TOBIN SCHILKE</name>
                <address>
                    <ns2:street1>1222 Demonbreun Street, Suite 2000</ns2:street1>
                    <ns2:city>Nashville</ns2:city>
                    <ns2:stateOrCountry>TN</ns2:stateOrCountry>
                    <ns2:zipCode>37203</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>common</securitiesClassTitle>
            <saleDate>04/03/2023</saleDate>
            <amountOfSecuritiesSold>3201</amountOfSecuritiesSold>
            <grossProceeds>102719.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>TOBIN SCHILKE</name>
                <address>
                    <ns2:street1>1222 Demonbreun Street, Suite 2000</ns2:street1>
                    <ns2:city>Nashville</ns2:city>
                    <ns2:stateOrCountry>TN</ns2:stateOrCountry>
                    <ns2:zipCode>37203</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>common</securitiesClassTitle>
            <saleDate>03/09/2023</saleDate>
            <amountOfSecuritiesSold>18517</amountOfSecuritiesSold>
            <grossProceeds>584303.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>06/02/2023</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>11/18/2022</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Tobin C Schilke</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 6771}]
144
0001678984
XXXXXXXX
LIVE
0001479290
REVANCE THERAPEUTICS, INC.
001-36297
1222 Demonbreun Street, Suite 2000
Nashville
TN
37203
(615) 724-7755
TOBIN SCHILKE
Officer
Common
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
500
15500.00
84040352
06/02/2023
NASD
COMMON
02/15/2021
Restricted Stock
ISSUER
N
500
02/15/2021
Not Applicable
N
TOBIN SCHILKE
1222 Demonbreun Street, Suite 2000
Nashville
TN
37203
Common
06/01/2023
2701
82569.57
TOBIN SCHILKE
1222 Demonbreun Street, Suite 2000
Nashville
TN
37203
common
05/15/2023
21401
738674.00
TOBIN SCHILKE
1222 Demonbreun Street, Suite 2000
Nashville
TN
37203
Common
05/01/2023
3201
101471.70
TOBIN SCHILKE
1222 Demonbreun Street, Suite 2000
Nashville
TN
37203
common
04/03/2023
3201
102719.00
TOBIN SCHILKE
1222 Demonbreun Street, Suite 2000
Nashville
TN
37203
common
03/09/2023
18517
584303.00
06/02/2023
11/18/2022
/s/ Tobin C Schilke